The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.a

Pulmonary edema, noncardiogenic (NCPE)

Publications

Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH

Acute pulmonary edema in pregnancy.

Obstetrics and gynecology. 2003;101(3):511-5

Benedetti TJ, Hargrove JC, Rosene KA

Maternal pulmonary edema during premature labor inhibition.

Obstetrics and gynecology. 1982;59(6 Suppl):33S-7S

Pisani RJ, Rosenow EC 3rd

Pulmonary edema associated with tocolytic therapy.

Annals of internal medicine. 1989;110(9):714-8

Stubblefield PG

Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: a case report.

American journal of obstetrics and gynecology. 1978;132(3):341-2